Back to Search

MARK GARZOTTO, MD

MD

Urology Physician

NPI: 1619982139Individual

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

MD22159(OR)

Research & Publications (20)

Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies.
PMID 16130139·Cancer·2005
8-other
Improved detection of prostate cancer using classification and regression tree analysis.
PMID 15781880·J Clin Oncol·2005
8-other
Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
PMID 14508828·Cancer·2003
4-observational
Current concepts in risk factor assessment for advanced germ cell cancer.
PMID 11561983·Semin Urol Oncol·2001
6-review
Syndrome of inappropriate antidiuretic hormone secretion: a rare complication of prostate cancer.
PMID 11547083·J Urol·2001
5-case
Combined androgen deprivation with radiotherapy for prostate cancer: does it make sense?
PMID 11062376·Mol Urol·2000
6-review
Historical perspective on prostate brachytherapy.
PMID 10910145·J Endourol·2000
8-other
Lower urinary tract symptoms increase the risk of falls in older men.
PMID 19154508·BJU Int·2009
4-observational
Prostate cancer-associated gene expression alterations determined from needle biopsies.
PMID 19366833·Clin Cancer Res·2009
4-observational
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer.
PMID 18782306·BJU Int·2008
3-trial
Veterans Affairs Cooperative Studies Program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer.
PMID 18407333·Urology·2008
6-review
Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy.
PMID 17482937·Urology·2007
8-other
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.
PMID 17382720·J Urol·2007
3-trial
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer.
PMID 17639587·Cancer·2007
3-trial
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer.
PMID 17066293·Cancer Chemother Pharmacol·2007
3-trial
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
PMID 17908975·Clin Cancer Res·2007
3-trial
Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy.
PMID 16469580·J Urol·2006
8-other
Effect of calcitriol on prostate-specific antigen in vitro and in humans.
PMID 16675575·Clin Cancer Res·2006
8-other
Testosterone loss and estradiol administration modify memory in men.
PMID 16406889·J Urol·2006
8-other
Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
PMID 16740769·Clin Cancer Res·2006
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239

Location

Practice Location

3181 SW SAM JACKSON PARK RD, PORTLAND, OR
(503) 494-7760

Quick Facts

NPI
1619982139
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile